Fact-checked by Grok 2 weeks ago

Tracheobronchitis

Tracheobronchitis is an acute inflammation of the trachea (windpipe) and bronchi (the major air passages leading to the lungs) in humans and animals, typically caused by viral or bacterial infections and lasting a few weeks. In animals, particularly dogs, it is known as and is highly contagious in group settings. It is often synonymous with and affects approximately 5% of adults annually, with most cases resolving without complications. The primary causes of tracheobronchitis are infectious agents, with about 95% of cases resulting from viruses such as those causing the or , while bacterial infections like account for roughly 5%. Noninfectious triggers include exposure to irritants such as cigarette smoke, dust, allergens, or chemical fumes, particularly in individuals with weakened immune systems or underlying respiratory conditions. In hospitalized or intubated patients, ventilator-associated tracheobronchitis can develop after 48 hours of , increasing the risk of progression to due to bacterial colonization. Common symptoms include a persistent productive , sore throat, fatigue, runny nose, and mild fever, which usually peak within the first week and subside over 1–3 weeks. In more severe cases, patients may experience , wheezing, chest discomfort, or (a high-pitched ), signaling potential airway obstruction. Diagnosis typically involves a , review of , and, if needed, imaging like a chest to rule out or other complications. Treatment focuses on symptom management and supportive care, as most viral cases resolve spontaneously without antibiotics. Over-the-counter remedies such as acetaminophen for pain and fever, increased fluid intake, rest, and humidified air can alleviate discomfort, while antibiotics are reserved for confirmed bacterial infections or secondary complications like . In ventilator-associated cases, prompt antibiotic therapy is often necessary to prevent escalation to life-threatening , with overall mortality rates of 20–50% in critically ill patients (as of 2021). Prevention strategies emphasize avoiding respiratory irritants and infections through measures like quitting , reducing exposure to pollutants, practicing good hand , and staying up-to-date on vaccinations for and other preventable respiratory viruses. Individuals at higher risk, such as those with chronic lung diseases or immunocompromised states, should consult healthcare providers for personalized preventive advice. Unlike chronic bronchitis, which involves persistent lasting at least three months per year for two consecutive years and is often linked to long-term irritant exposure, tracheobronchitis is generally self-limiting and does not lead to permanent damage in uncomplicated cases.

Definition and Overview

Definition

Tracheobronchitis is defined as the of both the trachea and the bronchi, the major conducting airways of the . The trachea, commonly referred to as the windpipe, is a flexible tube approximately 10-12 cm long that connects the larynx to the and bifurcates at the carina into the right and left main bronchi, which then branch further to deliver air to the lungs. This typically manifests as an acute process that is self-limited, often resolving within 1 to 3 weeks with supportive care. Tracheobronchitis is typically acute and the most prevalent form, generally associated with transient episodes rather than persistent damage. forms, though less common, involve prolonged inflammation that may recur or persist over time and can overlap with chronic bronchitis. The term "tracheobronchitis" first appeared in in the mid-19th century; for instance, a 1932 study addressed it in relation to non-diphtheritic infections in children. Tracheobronchitis is distinguished from related conditions such as , which is limited to inflammation of the trachea alone, and , which primarily affects the bronchi without significant tracheal involvement. The condition occurs in both humans and animals; in dogs, it is known as infectious tracheobronchitis or .

Pathophysiology

Tracheobronchitis involves of the trachea and bronchi, characterized by an initial —often from infectious agents—that triggers a localized . This leads to epithelial damage and , manifesting as mucosal and increased production in the affected airways. These changes narrow the airway lumen and stimulate the as a protective mechanism to expel irritants and excess secretions. In some cases, the damaged becomes susceptible to secondary bacterial , potentially complicating the condition with superimposed , although the primary process remains driven by the initial insult. These alterations can lead to prolonged recovery if unresolved. The of acute tracheobronchitis is typically self-limited and reversible, with resolving within 1-3 weeks as the clears the trigger and tissue repairs itself without lasting structural changes. forms, when they occur, feature persistent due to repeated insults, resulting in ongoing hypersecretion and increased susceptibility to exacerbations, similar to chronic bronchitis.

Causes

Infectious Causes

Tracheobronchitis, also known as in animals or in humans, is primarily caused by infectious agents that target the upper and lower . In both humans and animals, pathogens are the most common initiators, often leading to primary infections that can predispose to secondary bacterial involvement. The condition is highly contagious and spreads efficiently in crowded or close-contact environments. In humans, common causes include , influenza viruses, parainfluenza viruses, and adenovirus, which account for the majority of acute tracheobronchitis cases, particularly during seasonal outbreaks. These viruses typically infect the epithelial lining of the trachea and bronchi, causing inflammation and excessive mucus production. Bacterial agents in humans are less frequent as primary causes but include , which is implicated in up to 10-20% of community-acquired respiratory infections, and , responsible for that can manifest as tracheobronchitis. Secondary bacterial invaders, such as or , may complicate infections, exacerbating symptoms in vulnerable populations. In animals, particularly , tracheobronchitis is often part of the canine infectious respiratory disease complex (CIRDC). Key viral agents include canine parainfluenza virus, canine adenovirus type 2, and canine distemper virus, which damage the respiratory mucosa and facilitate bacterial colonization. The primary bacterial pathogen is , a gram-negative bacterium that adheres to ciliated epithelial cells, causing paroxysmal coughing and present in up to 50-80% of cases in unvaccinated . Other bacterial contributors include spp., such as Mycoplasma cynos, and secondary pathogens like spp. or Haemophilus spp., which thrive in the damaged airways post-viral infection. Transmission of these infectious agents occurs primarily through airborne droplets from coughing or sneezing, as well as direct contact with contaminated surfaces or fomites, making outbreaks common in settings like for humans or kennels and shelters for . In canine cases, close confinement accelerates spread, with incubation periods of 3-10 days for most pathogens. Zoonotic potential is limited overall, but from infected pets can rarely transmit to immunocompromised humans, causing mild respiratory illness or, in severe cases, . Other agents, such as virus, pose no known risk to humans.

Non-Infectious Causes

Non-infectious causes of tracheobronchitis encompass environmental irritants, allergic responses, and mechanical or reflux-mediated factors that provoke in the trachea and bronchi without microbial involvement. These etiologies often manifest in acute exacerbations or contribute to chronic forms, particularly in susceptible individuals exposed to occupational or lifestyle risks. Environmental irritants, including smoke, air pollutants, dust, and chemical fumes, induce direct mucosal damage and inflammatory responses in the airways. For instance, acts as a potent irritant, causing epithelial and increased production that characterizes tracheobronchitis symptoms. Similarly, exposure to occupational toxins like vapors or industrial pollutants can trigger acute inflammation by irritating the , exacerbating underlying airway . from sources such as traffic emissions or biomass burning further contributes by promoting and bronchial . Allergic reactions play a significant role, particularly in individuals with , where exposure to aeroallergens like , dust mites, or pet dander leads to inflammation of the tracheobronchial mucosa. This process involves IgE-mediated degranulation, resulting in airway , , and cough-dominant symptoms akin to allergic . Such reactions are more prevalent in atopic patients and can mimic infectious tracheobronchitis, often requiring differentiation through allergy testing. Other contributing factors include mechanical insults and underlying systemic conditions. Aspiration of foreign bodies, such as food particles or small objects, can obstruct and inflame the tracheobronchial tree, leading to localized and secondary tracheobronchitis, especially in adults with altered . Trauma from prolonged endotracheal causes mucosal and pseudomembrane formation, a non-infectious variant of tracheobronchitis observed in intensive care settings. Additionally, (GERD) promotes microaspiration of into the airways, irritating the mucosa via chemical and vagally mediated reflexes, thereby increasing the risk of bronchitis-like inflammation. These non-infectious causes are more commonly associated with tracheobronchitis or acute triggers in high-risk groups, such as smokers and those in polluted environments, accounting for a notable portion of cases beyond the predominant infectious etiologies.

Clinical Presentation

Symptoms in Humans

Tracheobronchitis in humans primarily manifests as a persistent , which may initially be dry and irritating before becoming productive with clear, white, yellow, or green in about half of cases. This typically lasts 1 to 3 weeks, often intensifying at night and disrupting sleep. Associated symptoms commonly include a , low-grade fever or , chest discomfort or soreness from coughing, wheezing, , mild , body aches, and . These signs usually accompany an upper respiratory infection and contribute to overall during the illness. The condition typically presents with acute onset following a upper respiratory infection, with symptoms peaking within the first 3 to 5 days before gradually subsiding over 1 to 3 weeks, resolving without scarring or permanent damage to the airways in most cases. In individuals with risk factors such as or comorbidities like , symptoms may be more severe, prolonged, or prone to complications, including exacerbated wheezing or secondary infections.

Symptoms in Animals

In dogs, tracheobronchitis, commonly known as kennel cough or canine infectious tracheobronchitis, primarily manifests as a harsh, dry cough often described as a "goose honk," which may be followed by retching and gagging and is easily induced by excitement, exercise, or gentle pressure on the trachea. Serous to mucopurulent nasal discharge and a mild fever are also frequent, with the condition often occurring in outbreaks among dogs in close quarters such as kennels or boarding facilities. The cough typically diminishes in severity within the first 5 days but can persist for 10 to 20 days, with few additional systemic signs in uncomplicated cases. Behavioral changes in affected dogs may include lethargy, reduced appetite, and exercise intolerance, particularly if secondary bacterial infections lead to bronchopneumonia. Small breeds, such as Chihuahuas, are more prone to prolonged symptoms due to anatomical factors like tracheal collapse, which can exacerbate airway irritation and delay recovery. In , tracheobronchitis is less common than in and often presents with spasms of that are most severe after periods of rest or at the onset of activity, accompanied by a slight fever. The acute phase typically lasts 2 to 3 days, but the may persist for several weeks. In , tracheobronchitis often occurs as part of the equine complex, triggered by viruses such as equine herpesvirus types 1 and 4, with symptoms including , serous nasal discharge, fever (up to 107°F or 41.7°C), , , and inappetence. These signs usually appear 2 to 10 days after exposure and may progress to if secondary bacterial infections develop.

Diagnosis

History and Physical Examination

The diagnosis of tracheobronchitis begins with a thorough history and to assess clinical features and identify potential risk factors. In humans, the history typically reveals an acute onset of cough following an upper respiratory , often lasting 1-3 weeks, with associated symptoms such as , , and low-grade fever. Exposure history is crucial, including , environmental irritants like or allergens, and crowded settings that increase viral transmission risk; vaccination status, particularly for , should also be evaluated as it may influence susceptibility. Physical examination in humans focuses on vital signs and respiratory assessment, revealing mild , wheezing, or rhonchi on that may clear with coughing, alongside normal findings in other systems. Inspection may show signs of respiratory distress such as or use of accessory muscles. Red flags include high fever exceeding 100.4°F (38°C), , or worsening , which suggest complications or alternative diagnoses requiring urgent evaluation. Differential diagnosis clues from history and help distinguish tracheobronchitis from or ; for instance, the absence of high fever, , or on exam points away from , while a lack of history or episodic triggers differentiates it from . In animals, particularly where tracheobronchitis is commonly known as , the history emphasizes recent exposure to other dogs in high-risk environments like kennels, boarding facilities, or dog parks, with cough onset typically 5-10 days post-exposure. status against key pathogens such as , canine parainfluenza virus, and distemper is essential to assess, as incomplete heightens risk in group settings. Physical examination in dogs involves tracheal to elicit a characteristic dry, honking , with often revealing normal or mildly harsh sounds without in uncomplicated cases. Inspection may detect serous nasal discharge or mild respiratory effort, but affected animals are usually alert and active unless progression occurs. Red flags such as high fever, purulent discharge, lethargy, or productive signal potential secondary needing further investigation. For in animals, the paroxysmal nature of the induced by , without systemic signs like or fever, helps rule out (which features and ) or chronic conditions like analogs, which may show more persistent wheezing without infectious exposure .

Diagnostic Tests

of tracheobronchitis is typically clinical, based on and physical examination, with laboratory and imaging studies used when needed to exclude differentials such as if clinical findings are ambiguous or suggest complications. Chest radiography is a primary modality, often revealing peribronchial thickening or increased bronchial markings without evidence of , which helps differentiate tracheobronchitis from . In cases where is suspected—such as in patients with high fever, , or abnormal breath sounds—a chest is essential to rule out parenchymal involvement. Laboratory tests include (CBC), which may demonstrate indicative of a bacterial component, though this is nonspecific. (PCR) assays on nasopharyngeal swabs or sputum detect viral or bacterial pathogens, such as in humans or in dogs, providing etiologic confirmation. and are performed in suspected bacterial cases to identify organisms and guide , though routine use is limited in uncomplicated viral etiologies. In severe or persistent cases, allows direct visualization of the trachea and bronchi, revealing or mucus accumulation, and facilitates sample collection for cytology or culture. For veterinary patients, particularly with infectious tracheobronchitis, transtracheal or yields samples for cytologic examination, revealing inflammatory cells, and subsequent or culture to identify pathogens like or canine parainfluenza virus. These tests are selected based on initial clinical history and examination findings to target suspected etiologies efficiently.

Management and Treatment

Supportive Therapy

Supportive therapy for tracheobronchitis focuses on alleviating symptoms and promoting through non-pharmacological measures that maintain airway , reduce , and support overall comfort in both humans and animals. Adequate rest is essential, as it allows the body to direct energy toward healing inflamed airways, while encouraging sufficient fluid intake helps thin secretions, facilitating easier clearance from the . In humans, patients are advised to drink plenty of or clear fluids, aiming for at least 8-10 daily unless contraindicated, to prevent from becoming thick and obstructive. Similarly, in dogs with canine tracheobronchitis (often called ), owners should ensure access to fresh and monitor intake to avoid , which can exacerbate coughing. Avoiding environmental irritants, such as smoke, dust, or strong odors, is crucial for both species to minimize further airway inflammation and support natural resolution of symptoms. Humidification plays a key role in soothing irritated airways by adding moisture to inspired air, which can reduce coughing and improve . In humans, inhalation from a hot shower or the use of a cool-mist in the bedroom helps maintain airway hydration, particularly during dry seasons or in arid climates. Nebulized saline may also be employed under medical guidance to deliver targeted humidity directly to the . For dogs, exposing the animal to —such as sitting in a during a hot shower for 10-15 minutes several times a day—effectively thins and eases breathing without specialized equipment. These methods are particularly beneficial in mild cases, where they can shorten symptom duration by promoting expectoration of secretions. Cough management in supportive therapy emphasizes gentle, natural approaches to suppress irritation while allowing productive clearance. In humans over one year of age, a teaspoon of honey taken alone or in warm tea before bedtime can soothe the throat and reduce cough frequency, with studies showing it outperforms some over-the-counter remedies for nocturnal symptoms associated with upper respiratory infections. Honey is contraindicated for infants under one year due to the risk of botulism from bacterial spores. Environmental controls are vital for contagious forms, such as isolating affected individuals or animals to prevent spread; in veterinary settings, separating dogs with kennel cough for 1-2 weeks and disinfecting areas with bleach solutions helps contain outbreaks. These strategies complement any antimicrobial treatments by addressing symptomatic relief universally. Close monitoring is necessary to detect complications early, ensuring timely escalation of care. In humans, signs of —such as dry mouth, reduced urine output, or —warrant immediate medical attention, especially in children or those with persistent fever, as tracheobronchitis can lead to fluid loss from increased respiratory effort. For dogs, owners should watch for , refusal to eat, or sunken eyes indicating , consulting a if symptoms worsen beyond 7-10 days or if breathing becomes labored. Regular assessment of , including and hydration status, helps prevent progression to secondary issues like in vulnerable patients.

Specific Treatments

Specific treatments for tracheobronchitis target the underlying etiology, primarily infectious agents, and are selected based on clinical presentation, diagnostic findings, and patient population (human or animal). In bacterial cases, antimicrobials are employed judiciously to avoid promoting resistance, given the often self-limiting nature of the condition. For instance, in humans with suspected atypical bacterial pathogens such as Mycoplasma pneumoniae, Chlamydophila pneumoniae, or Bordetella pertussis, antibiotics like azithromycin (500 mg on day 1, followed by 250 mg daily for 4 days) or doxycycline (100 mg twice daily for 7-10 days) may be prescribed, potentially reducing cough duration by about 0.58 days on average, though evidence of significant benefit is limited. In severe bacterial tracheitis, particularly in children, initial airway management with intubation (required in 38-100% of cases) and ICU monitoring is essential to secure the airway and facilitate suctioning of purulent secretions, followed by broad-spectrum intravenous antibiotics such as ceftriaxone combined with clindamycin to cover pathogens like Staphylococcus aureus or Streptococcus, with a 10-14 day course to ensure resolution. Antivirals are rarely used outside of confirmed influenza-associated tracheobronchitis, where oseltamivir (75 mg twice daily for 5 days in adults) can shorten symptom duration by approximately 1 day if initiated within 48 hours of onset. For () in intubated patients, treatment involves prompt initiation of systemic antibiotics targeting common pathogens such as or spp., typically with combinations like plus piperacillin-tazobactam for 7-14 days, alongside continued support and surveillance cultures to prevent progression to . In , particularly for canine infectious tracheobronchitis () involving or spp., remains the first-line antimicrobial at 5 mg/kg orally every 12 hours or 10 mg/kg every 24 hours for 7-10 days, due to its efficacy against these agents and good tolerability in dogs. Amoxicillin-clavulanate (11-22 mg/kg orally every 12 hours) serves as an alternative for secondary bacterial infections. Protocols emphasize empirical use only in cases with fever, , or , with an initial 10-day observation period recommended for mild cases to minimize antibiotic overuse, as the condition is frequently viral and self-resolves. Bronchodilators, such as inhaled albuterol (via or ), are indicated for patients exhibiting wheezing or airflow obstruction, providing symptomatic relief in subsets with , though they do not shorten overall illness duration in uncomplicated cases. Anti-inflammatory agents like systemic corticosteroids (e.g., 40-60 mg daily for 5 days in adults) may be considered for severe inflammation or in patients with underlying conditions like or COPD, but inhaled corticosteroids lack supporting evidence for routine use. Cough suppressants, such as , are used cautiously in humans to alleviate severe, non-productive cough, but antihistamines and other antitussives offer no proven benefit and may exacerbate retention. In veterinary settings, similar bronchodilators and anti-inflammatories are applied selectively for symptomatic control, complementing supportive measures like .

Prevention

Measures in Humans

Preventing tracheobronchitis in humans primarily involves strategies to reduce exposure to respiratory viruses and irritants, as the condition is most often caused by viral infections such as or . Good practices are foundational, including frequent handwashing with and water for at least 20 seconds, especially after contact with public surfaces or individuals showing respiratory symptoms. Additionally, covering the mouth and with a or when coughing or sneezing, and avoiding close contact with people who have colds or flu, helps limit viral transmission, particularly during peak respiratory seasons like winter. Staying home when ill further prevents spreading pathogens to others. Lifestyle modifications play a key role in lowering risk, with smoking cessation being one of the most effective measures, as tobacco smoke irritates the tracheobronchial mucosa and increases susceptibility to infections. Annual influenza vaccinations are strongly recommended for all adults, as flu viruses trigger many cases of acute tracheobronchitis; these shots can reduce infection rates by 40-60% in vaccinated populations. For broader protection, updated COVID-19 vaccines are recommended for all eligible individuals, while RSV vaccines are advised for adults aged 75 and older, adults aged 60-74 at increased risk for severe RSV, and pregnant people at 32-36 weeks gestation to protect infants, especially since these infections can mimic or lead to tracheobronchitis symptoms. Environmental controls are essential for minimizing irritants that exacerbate or precipitate the condition. Using air purifiers or filters can help reduce indoor allergens, dust, and pollutants, thereby decreasing airway inflammation in susceptible individuals. Prompt treatment of () is also important, as chronic acid reflux can irritate the and bronchi, heightening risk; management with inhibitors or lifestyle changes like elevating the head during is beneficial. For high-risk groups such as the elderly or immunocompromised, annual influenza vaccinations are particularly emphasized, along with pneumococcal vaccines to prevent secondary bacterial complications. These individuals should also prioritize avoiding crowded indoor spaces during outbreak seasons.

Measures in Animals

Prevention of tracheobronchitis in animals primarily relies on protocols tailored to high-risk environments such as kennels and boarding facilities. For dogs, the vaccine is a key component, available in intranasal, injectable, or oral forms, with intranasal administration preferred in shelters for its rapid onset of immunity within days. This noncore is often incorporated into the puppy vaccination series starting at 6-8 weeks of age, with boosters recommended every 6-12 months for dogs in social settings, alongside core vaccines like those for distemper, adenovirus-2, and parainfluenza virus that provide partial protection against the canine infectious respiratory disease complex (CIRDC). Quarantine and isolation are essential to curb transmission in group housing. Newly introduced dogs in boarding facilities or shelters should be quarantined for at least 14 days or until fully vaccinated to prevent introducing the , while symptomatic animals require immediate in separate areas to avoid aerosol spread. Disinfection protocols involve thorough cleaning of affected areas with effective agents like diluted (1:32 ratio), followed by drying, as the bacteria and viruses can persist on surfaces; facilities should maintain dedicated rooms with separate ventilation and entry points. Herd management strategies focus on minimizing and in collective settings like kennels or farms. Avoiding reduces direct contact and , with recommendations to limit group sizes, ensure adequate space (at least 12 square feet per in shelters), and optimize , , and to bolster respiratory . These practices, combined with routine health screening, help achieve thresholds through widespread . In , tracheobronchitis often occurs as part of feline upper respiratory infections caused by viruses such as feline herpesvirus-1 (FHV-1) and (FCV). Prevention centers on core vaccination with the FVRCP vaccine, which protects against FHV-1, FCV, and panleukopenia, typically administered starting at 6-8 weeks of age with boosters every 1-3 years depending on risk. Non-core vaccines for Chlamydia felis may be considered in multi-cat environments. Additional measures include quarantining new for 1-2 weeks, maintaining good to reduce and bacterial overgrowth, and avoiding in catteries or shelters. In other species, such as , prevention targets related respiratory viruses causing similar upper airway inflammation. Vaccines against virus, equine herpesvirus-1 and -4, and Streptococcus equi () are recommended, with boosters every 6 months for at-risk per American Association of Equine Practitioners guidelines, alongside measures like avoiding communal water sources.

Prognosis and Complications

Tracheobronchitis is generally self-limiting with a favorable prognosis in most cases. In humans, the condition typically resolves within 1–3 weeks without specific , particularly when caused by infections. is usually complete, with no long-term damage in uncomplicated cases. However, prognosis may be poorer in vulnerable populations, such as young children, older adults, or those with underlying conditions like (COPD) or , where symptoms may persist longer or lead to secondary issues. In animals, particularly dogs affected by infectious tracheobronchitis (commonly known as ), the prognosis is also excellent for healthy individuals, with most recovering fully within 7–14 days through supportive care. Puppies, senior dogs, or those with compromised immune systems face higher risks of prolonged illness. Complications are uncommon in otherwise healthy individuals but can occur, especially in severe or untreated cases. In humans, the most frequent complication is secondary , which develops when the infection spreads to the lung parenchyma. This risk is elevated in , where bacterial can progress to , associated with mortality rates of 5–10% in intensive care settings. Rare complications include , , and exacerbation of preexisting respiratory conditions. Recurrent episodes may contribute to the development of chronic bronchitis over time. In animals, complications primarily involve progression to , particularly in young or debilitated , which can lead to , , and in severe cases, respiratory distress requiring hospitalization. Chronic may develop in older or repeatedly exposed animals. Early typically prevents these outcomes.

References

  1. [1]
    Tracheobronchitis: Symptoms, causes, treatment, and more
    Jul 20, 2023 · Tracheobronchitis may cause symptoms that include coughing, a sore throat, and tiredness. Causes can include viruses, bacteria, and air ...Missing: veterinary | Show results with:veterinary
  2. [2]
    Tracheobronchitis: Treatments and Comparison to Chronic Bronchitis
    Feb 1, 2018 · Tracheobronchitis occurs when the windpipe or bronchi become inflamed. This is usually due to a viral or bacterial infection, ...
  3. [3]
    Medical Definition of TRACHEOBRONCHITIS - Merriam-Webster
    The meaning of TRACHEOBRONCHITIS is inflammation of the trachea and bronchi.
  4. [4]
    Trachea (Windpipe): Function and Anatomy - Cleveland Clinic
    The trachea is the tube connecting your voice box to your bronchi. Your bronchi send air to your lungs. Your trachea is often called your windpipe.
  5. [5]
  6. [6]
    Acute Bronchitis and Tracheitis - PMC - PubMed Central - NIH
    The term acute bronchitis and tracheitis defines a self-limited (1 to 3 weeks) inflammation of the large airways of the lung that extends to the tertiary ...Definition · Figure 96-1 · Diagnosis
  7. [7]
    Special Reference to Non-Diphtheritic Infections - T. R. Gittins, 1932
    Research article. First published June 1932. XXXIII. Laryngitis and Tracheobronchitis in Children: Special Reference to Non-Diphtheritic Infections. T. R. ...
  8. [8]
    Acute Bronchitis - StatPearls - NCBI Bookshelf
    Mar 9, 2024 · The majority (90%) of cases are caused by viruses, resulting in inflammation and increased mucus production. Occasionally, secondary pneumonia ...
  9. [9]
    Chronic Bronchitis and Chronic Obstructive Pulmonary Disease - PMC
    It is caused by excess mucus production, hypersecretion, and mucociliary dysfunction resulting from persistent airway inflammation. Management strategies ...Missing: tracheobronchitis | Show results with:tracheobronchitis
  10. [10]
    Upper Respiratory Infections and Acute Bronchitis - PMC - NIH
    A wide variety of viruses have been shown as causes of acute bronchitis including influenza, rhinovirus, adenovirus, coronavirus, parainfluenza, and respiratory ...Uncomplicated Upper... · Acute Otitis Media · Tonsillitis/pharyngitis<|control11|><|separator|>
  11. [11]
    Infectious Causes of Chronic Inflammatory Diseases and Cancer
    M. pneumoniae is a common cause of both upper and lower respiratory infection in humans; tracheobronchitis is the most common clinical manifestation (45). ...
  12. [12]
    Canine Infectious Respiratory Disease Complex (CIRDC, a.k.a. ...
    Aug 9, 2023 · Multiple bacterial and viral pathogens, acting both sequentially and synergistically, are associated with CIRDC. Viral pathogens associated with ...
  13. [13]
    Publication : USDA ARS
    Technical Abstract: Infection with Bordetella bronchiseptica is a common cause of tracheobronchitis and upper respiratory disease in dogs and cats, but it ...
  14. [14]
    Antimicrobial use Guidelines for Treatment of Respiratory Tract ...
    Feb 10, 2017 · Respiratory tract disease can be associated with primary or secondary bacterial infections in dogs and cats and is a common reason for use and ...Canine Infectious... · Bacterial Bronchitis In Dogs... · Pneumonia In Dogs And Cats
  15. [15]
    The risks of kennel cough | Cornell University College of Veterinary ...
    Transmission occurs via droplets released when dogs sneeze or cough, dog-to-dog contact and through contaminated items (door handles, food and water bowls).Missing: tracheobronchitis | Show results with:tracheobronchitis
  16. [16]
    Aetiology of Canine Infectious Respiratory Disease Complex and ...
    Mar 17, 2020 · It commonly spreads where large numbers of dogs are housed in close confinement (e. g. in shelters or boarding kennels) or are gathered (e. g. ...
  17. [17]
    Zoonotic Transmission of Vaccine-Derived Bordetella bronchiseptica
    Aug 7, 2023 · In cats and dogs, B. bronchiseptica is highly contagious, leading to bronchitis (kennel cough). In humans, B. bronchiseptica infections are rare ...Missing: tracheobronchitis | Show results with:tracheobronchitis
  18. [18]
    Acute Bronchitis - DynaMed
    Noninfectious causes include allergic or irritating substances such as cigarette smoke, air pollutants, or inhaled ammonia. 1. Pathogenesis. Bronchial edema ...
  19. [19]
    Bronchitis - Symptoms and causes - Mayo Clinic
    Jul 31, 2024 · Bronchitis is an inflammation of the lining of your bronchial tubes. These tubes carry air to and from your lungs.Overview · Symptoms · Causes
  20. [20]
    Bronchitis: Causes, Symptoms, Diagnosis & Treatment
    Bronchitis is when the airways leading to your lungs (trachea and bronchi) get inflamed and fill with mucus. It gives you a cough that lasts for two or more ...Missing: veterinary | Show results with:veterinary
  21. [21]
    Foreign-Body Aspiration, Asthma and Chronic Bronchitis - AAFP
    Oct 1, 2000 · This case illustrates that foreign-body aspiration must be considered as one of several possible etiologies in patients presenting with respiratory distress.Missing: tracheobronchitis | Show results with:tracheobronchitis
  22. [22]
  23. [23]
    Pulmonary manifestations of gastroesophageal reflux disease - PMC
    GERD can cause various pulmonary manifestations: Chronic cough, bronchial asthma, bronchitis, pneumonia and interstitial fibrosis.
  24. [24]
    Chest Cold (Acute Bronchitis) Basics - CDC
    Apr 17, 2024 · The most common symptom of acute bronchitis is coughing with or without mucus. Symptoms of acute bronchitis last less than 3 weeks.Missing: tracheobronchitis humans
  25. [25]
    Overview: Acute bronchitis - InformedHealth.org - NCBI Bookshelf
    Apr 18, 2023 · People often cough at night, which disturbs their sleep. If acute bronchitis occurs together with a cold, many of those affected have other ...Symptoms · Causes · Prevalence and outlook · Diagnosis
  26. [26]
    Kennel Cough - Respiratory System - Merck Veterinary Manual
    The prominent clinical sign of kennel cough is a cough that sounds like a "goose honk" that may be followed by retching and gagging. The cough is easily induced ...
  27. [27]
    Tracheobronchitis (Bronchitis) in Dogs - Merck Veterinary Manual
    Tracheobronchitis is a sudden or longterm inflammation of the trachea and bronchial airways; it may also extend into the lungs.
  28. [28]
    Clinical Update - Role of Bordetella bronchiseptica in infectious ...
    * Coughing along with gagging or retching behavior seems to be the most con- sistent clinical sign of ITB. ' Nasal discharge is less fre- quently evident. ...
  29. [29]
    What Is Dog Bronchitis: Signs, Symptoms, and Treatments
    Aug 23, 2024 · Dr. Klein warns that chronic bronchitis in dogs is most often seen in smaller breeds, but larger breeds can get it too.Missing: prolonged | Show results with:prolonged
  30. [30]
    Tracheobronchitis (Bronchitis, Bronchial Asthma) in Cats - Cat Owners
    Spasms of coughing are the most prominent sign; it is most severe after rest or at the beginning of exercise. A slight fever may also be noted. The acute stage ...
  31. [31]
    Equine Herpesvirus Infection - Respiratory System
    Fever, nasal discharge, malaise, pharyngitis, and cough are key symptoms. ... tracheobronchitis. The natural reservoir of both EHV-1 and EHV-4 is the ...
  32. [32]
    Bacterial Tracheitis - StatPearls - NCBI Bookshelf
    Jun 30, 2023 · Bacterial tracheitis is a potentially lethal infection of the subglottic trachea. It is often a secondary bacterial infection preceded by a viral infection ...
  33. [33]
    Diagnosis and Treatment of Acute Bronchitis - AAFP
    Dec 1, 2010 · Acute bronchitis should be differentiated from other common diagnoses, such as pneumonia and asthma, because these conditions may need specific ...
  34. [34]
    Canine Infectious Respiratory Disease - PMC - PubMed Central
    Nosocomial outbreak of serious canine infectious tracheobronchitis (kennel cough) caused by canine herpesvirus infection. J Clin Microbiol. 2010;48:1176 ...Canine Infectious... · Canine Influenza Virus · Canine Parainfluenza Virus<|control11|><|separator|>
  35. [35]
    Acute Bronchitis - Pulmonary Disorders - Merck Manuals
    Evaluation for noninfectious causes of chronic cough, such as asthma (including cough-variant asthma), postnasal drip, and gastroesophageal reflux disease ...
  36. [36]
    Bronchitis - Diagnosis and treatment - Mayo Clinic
    Jul 31, 2024 · The lining of the tubes that carry air to and from your lungs is inflamed. Signs and symptoms include cough, mucus, fatigue and chest ...Diagnosis · Preparing For Your... · What To Expect From Your...Missing: tracheobronchitis | Show results with:tracheobronchitis<|control11|><|separator|>
  37. [37]
    Kennel Cough - Respiratory System - MSD Veterinary Manual
    (Canine Infectious Tracheobronchitis) ... Kennel cough results from inflammation of the trachea. It is a mild, self-limiting disease but may progress to ...Missing: definition | Show results with:definition
  38. [38]
    Kennel Cough in Dogs: Causes, Symptoms, & Treatment
    Oct 28, 2025 · What Are the Symptoms of Kennel Cough? · Strong cough, often with a “honking” sound (the most obvious symptom) · Runny nose · Sneezing ...Missing: diagnosis | Show results with:diagnosis
  39. [39]
    Heated air humidification versus cold air nebulization in newly ... - NIH
    Results indicate a potential advantage of hydration with heated and humidified air over the conventional nebulization of cold saline solution after a ...
  40. [40]
    Pneumonia in Dogs: Signs, Symptoms, and Treatments
    Oct 29, 2025 · Sit with your dog for 15 minutes in the bathroom after running a hot shower to create steam. The steam and humidity can help thin out the mucus ...
  41. [41]
    Honey: An effective cough remedy? - Mayo Clinic
    Several studies focusing on the common cold suggest that honey may help calm coughs in adults and children over 1 year of age.
  42. [42]
    Honey for treatment of cough in children - PMC - PubMed Central
    A single dose of honey before bedtime was shown in recent studies to diminish cough and the discomfort experienced by children and their parents.
  43. [43]
    Cough - Mayo Clinic
    Think about taking honey. A teaspoon of honey may help loosen a cough. Don't give honey to children younger than 1 year old because honey can contain bacteria ...<|separator|>
  44. [44]
    Take Precautions to Prevent Kennel Cough
    Feb 8, 2018 · Once kennel cough has come into a kennel, it is best to clear out the kennel for one-to-two weeks and clean with common disinfectants (such as bleach).Missing: supportive | Show results with:supportive
  45. [45]
    Bronchiolitis - Diagnosis and treatment - Mayo Clinic
    May 4, 2024 · Your child's provider may look for symptoms of dehydration, especially if your child has been refusing to drink or eat or has been vomiting.Diagnosis · Treatment · Lifestyle And Home Remedies
  46. [46]
    Laryngotracheobronchitis - StatPearls - NCBI Bookshelf - NIH
    Laryngotracheobronchitis, as the name implies, refers to inflammation of the larynx, trachea, and bronchi. Cases of laryngotracheobronchitis can be more severe ...
  47. [47]
    Canine influenza | American Veterinary Medical Association
    What are the signs of canine influenza? · Persistent cough · Thick nasal discharge · Fever (often 104-105oF) · Lethargy · Runny eyes · Reduced appetite.
  48. [48]
    Antimicrobial use Guidelines for Treatment of Respiratory Tract ... - NIH
    Doxycycline is believed to have clinical activity against Mycoplasma. As in cats, doxycycline is well tolerated by dogs and isolates of B. bronchiseptica from ...
  49. [49]
    Understanding Bronchitis: A Doctor Answers Your FAQs
    Oct 28, 2024 · Simple hygiene practices like frequent hand washing, covering your mouth and nose when coughing or sneezing, staying home when you are sick can ...
  50. [50]
    Acute Bronchitis - Harvard Health
    Feb 2, 2024 · Acute bronchitis caused by an infection usually starts with an upper respiratory illness, such as the common cold or flu (influenza), that ...Missing: humans | Show results with:humans
  51. [51]
    [PDF] Preventing and Treating Bronchitis | CDC
    Side effects can range from minor issues, like a rash, to very serious health problems, such as antimicrobial-resistant infections and C. diff infection, which ...Missing: tracheobronchitis | Show results with:tracheobronchitis
  52. [52]
    Which Bordetella Vaccine to Use and Why?
    For shelters, intranasal (IN) Bordetella vaccine is recommended due to its single dose, rapid immunity, and bivalent/trivalent options. SQ requires two doses.
  53. [53]
    Bordetella Vaccine for Dogs - PetMD
    Jan 26, 2024 · The Bordetella vaccine is a safe and effective option to prevent kennel cough in dogs. It can be given orally, nasally, or by injection underneath the skin.
  54. [54]
    [PDF] Infectious Disease Protocol: Canine Kennel Cough (CIRDC)
    • Quarantine exposed dogs for 14 days after treatment begins. • If neither isolation nor quarantine are an option, the only other humane alternative is.
  55. [55]
    [PDF] Kennel and Boarding Safety Recommendations - Merck Animal Health
    Keep in mind when you are disinfecting that all areas need to be cleaned beforehand, including the cage, the materials in the cage, the floor outside the cage, ...
  56. [56]
    [PDF] Canine Respiratory Infections in Shelters UF Maddie's Shelter ...
    The most effective way is to prevent crowding by practicing sound population management strategies that decrease each animal's length of stay in the shelter.
  57. [57]
    Controlling disease transmission in animal shelters - DVM360
    Some examples of canine diseases are parvo, infectious tracheobronchitis ... Overcrowding should be viewed as a serious shelter problem to be avoided ...
  58. [58]
    [PDF] 2022 AAHA Canine Vaccination Guidelines
    Vaccines have mitigated the impact of infectious diseases on populations through herd immunity so successfully that some dog owners may hold the perception that.
  59. [59]
    Overview of Respiratory Diseases of Horses
    Vaccines are commercially available for equine influenza, viral rhinopneumonitis, equine viral arteritis, and strangles.Missing: tracheobronchitis | Show results with:tracheobronchitis
  60. [60]